Daya Verma

USPTO Granted Patents = 5 (Patent Applications = 2)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 20(Granted Patents)

Company Filing History:

Supernus Pharmaceuticals, Inc.

patents

Years Active: 2016-2020

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10561654 - Pharmaceutical formulations of (S)-methyl(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (2020-02-18),

2. 10258622 - Method of treating colorectal cancer by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)pheny1)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl) carbamate (2019-04-16),

3. 9763941 - Method of treating melanoma by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (2017-09-19),

4. 9744137 - Topiramate compositions and methods of enhancing its bioavailability (2017-08-29),

5. 9387208 - Pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (2016-07-12),

Title: Daya Verma: Innovator in Pharmaceutical Formulations

Introduction

Daya Verma is a notable inventor based in Edison, NJ (US), recognized for his contributions to the field of pharmaceutical formulations. With a total of 5 patents, he has made significant strides in developing innovative treatments for various diseases.

Latest Patents

Among his latest patents, Daya Verma has focused on the pharmaceutical formulations of (S)-methyl(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate. This invention relates to solid oral pharmaceutical formulations of this compound and their use in treating proliferative diseases, including solid tumor diseases. Another significant patent involves a method of treating colorectal cancer through the administration of these formulations, showcasing his commitment to addressing critical health challenges.

Career Highlights

Daya Verma has worked with prominent companies in the pharmaceutical industry, including Array Biopharma Inc. and Novartis AG. His experience in these organizations has contributed to his expertise in developing effective pharmaceutical solutions.

Collaborations

Throughout his career, Daya has collaborated with talented individuals such as Xiaohong Shen and Hanchen Lee, enhancing the innovation process through teamwork and shared knowledge.

Conclusion

Daya Verma's work in pharmaceutical formulations exemplifies the impact of innovation in healthcare. His patents and collaborations reflect a dedication to improving treatment options for patients facing serious health conditions.

This text is generated by artificial intelligence and may not be accurate.